<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35594336</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Pathophysiology and mechanism of long COVID: a comprehensive review.</ArticleTitle><Pagination><StartPage>1473</StartPage><EndPage>1487</EndPage><MedlinePgn>1473-1487</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2022.2076901</ELocationID><Abstract><AbstractText Label="BACKGROUND">After almost 2 years of fighting against SARS-CoV-2 pandemic, the number of patients enduring persistent symptoms long after acute infection is a matter of concern. This set of symptoms was referred to as "long COVID", and it was defined more recently as "Post COVID-19 condition" by the World health Organization (WHO). Although studies have revealed that long COVID can manifest whatever the severity of inaugural illness, the underlying pathophysiology is still enigmatic.</AbstractText><AbstractText Label="AIM">To conduct a comprehensive review to address the putative pathophysiology underlying the persisting symptoms of long COVID.</AbstractText><AbstractText Label="METHOD">We searched 11 bibliographic databases (Cochrane Library, JBI EBP Database, Medline, Embase, PsycInfo, CINHAL, Ovid Nursing Database, Journals@Ovid, SciLit, EuropePMC, and CoronaCentral). We selected studies that put forward hypotheses on the pathophysiology, as well as those that encompassed long COVID patients in their research investigation.</AbstractText><AbstractText Label="RESULTS">A total of 98 articles were included in the systematic review, 54 of which exclusively addressed hypotheses on pathophysiology, while 44 involved COVID patients. Studies that included patients displayed heterogeneity with respect to the severity of initial illness, timing of analysis, or presence of a control group. Although long COVID likely results from long-term organ damage due to acute-phase infection, specific mechanisms following the initial illness could contribute to the later symptoms possibly affecting many organs. As such, autonomic nervous system damage could account for many symptoms without clear evidence of organ damage. Immune dysregulation, auto-immunity, endothelial dysfunction, occult viral persistence, as well as coagulation activation are the main underlying pathophysiological mechanisms so far.</AbstractText><AbstractText Label="CONCLUSION">Evidence on why persistent symptoms occur is still limited, and available studies are heterogeneous. Apart from long-term organ damage, many hints suggest that specific mechanisms following acute illness could be involved in long COVID symptoms. KEY MESSAGESLong-COVID is a multisystem disease that develops regardless of the initial disease severity. Its clinical spectrum comprises a wide range of symptoms.The mechanisms underlying its pathophysiology are still unclear. Although organ damage from the acute infection phase likely accounts for symptoms, specific long-lasting inflammatory mechanisms have been proposed, as well.Existing studies involving Long-COVID patients are highly heterogeneous, as they include patients with various COVID-19 severity levels and different time frame analysis, as well.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Castanares-Zapatero</LastName><ForeName>D</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7112-2070</Identifier><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalon</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohn</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dauvrin</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Detollenaere</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maertens de Noordhout</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Primus-de Jong</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cleemput</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Heede</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">pathology</Keyword><Keyword MajorTopicYN="N">physiology</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>13</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35594336</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, et al. . COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021;58(5):1473&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S.. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2021;e2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani DP, Gaughan C. Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. [cited 2021 Sept 16]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021.</Citation></Reference><Reference><Citation>WHO.  A clinical CAS definition of post COVID condition by a Delphy consensus. World health Organization (WHO); 2021. A clinical CAS definition of post COVID condition by a Delphy consensus Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Long QX, Tang XJ, Shi QL, et al. . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200&#x2013;1204.</Citation><ArticleIdList><ArticleId IdType="pubmed">32555424</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. . Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12):ofaa509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero DK, Dauvrin M, Detollenaere J, et al.  Long COVID: pathophysiology &#x2013; epidemiology and patient needs. Federaal Kenniscentrum voor de Gezondheidszorg-Centre F&#xe9;d&#xe9;ral d'Expertise des Soins de Sant&#xe9;. 2021. Available from: https://kce.fgov.be/sites/default/files/atoms/files/KCE_344_Long_Covid_scientific_report_1.pdf.</Citation></Reference><Reference><Citation>Motiejunaite J, Balagny P, Arnoult F, et al. . Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Front Physiol. 2020;11:614590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ.. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Deleterious outcomes in Long-Hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020;11(24):4017&#x2013;4020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Boucas AP, Rheinheimer J, Lagopoulos J.. Why severe COVID-19 patients are at greater risk of developing depression: a molecular perspective. Neuroscientist. 2022;28(1):11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33135582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. . Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med. 2021;21(1):e63&#x2013;e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin GA, Snyder H, Carrillo M, et al. . The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning. Alzheimers Dement. 2021;17(6):1056&#x2013;1065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H.. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16&#x2013;27.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA.. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed. Health Behav. 2020;8(2):61&#x2013;69.</Citation></Reference><Reference><Citation>Kazama I. Stabilizing mast cells by commonly used drugs: a novel therapeutic target to relieve post-COVID syndrome? Drug Discov Ther. 2020;14(5):259&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">33116043</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A.. A cytokine-based model for the pathophysiology of long COVID symptoms. SciLIT. (preprints). 2020.</Citation></Reference><Reference><Citation>Mukaetova-Ladinska EB, Kronenberg G, Raha-Chowdhury R.. COVID-19 and neurocognitive disorders. Curr Opin Psychiatry. 2021;34(2):149&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924920</ArticleId><ArticleId IdType="pubmed">33395101</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S, Najjar A, Chong DJ, et al. . Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflamm. 2020;17(1):231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogier M, Andeol G, Sagui E, et al. . How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up. Brain Behav Immun Health. 2020;5:100081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227537</ArticleId><ArticleId IdType="pubmed">32427134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9(3):e14726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro DE, Oliveira-Giacomelli A, Glaser T, et al. . Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2021;26(4):1044&#x2013;1059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738776</ArticleId><ArticleId IdType="pubmed">33328588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T, Fietsam AC, Deters JR, et al. . Post-COVID-19 fatigue: potential contributing factors. Brain Sci. 2020;10(12):1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoppettuolo P, Borrelli S, Naeije G.. Neurological involvement in SARS-CoV-2 infection: a clinical systematic review. Brain Behav Immun Health. 2020;5:100094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832728</ArticleId><ArticleId IdType="pubmed">33521692</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L, Jr., Steardo L, Verkhratsky A.. Psychiatric face of COVID-19. Transl Psychiatry. 2020;10(1):261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391235</ArticleId><ArticleId IdType="pubmed">32732883</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, Ptacek R, Ptackova H, et al. . Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce &#x2018;brain fog&#x2019; and results in behavioral changes that favor viral survival. Med Sci Monit. 2021;27:e930886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S.. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W.. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis Transl Med. 2021;7(1):14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmulson M, Ghoshal UC, Barbara G.. Managing the inevitable surge of Post-COVID-19 functional gastrointestinal disorders. Am J Gastroenterol. 2021;116(1):4&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, Gul A, Baykan B.. COVID-19 is a real headache!. Headache. 2020;60(7):1415&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, Bayry J.. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16(8):413&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Veldhuis A, Malhotra T.. Neuropsychiatric and cognitive sequelae of COVID-19. Front Psychol. 2021;12:577529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7960660</ArticleId><ArticleId IdType="pubmed">33737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WJ, Hui CKM, Hull JH, et al. . Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JJL. Persistent SARS-2 infections contribute to long COVID-19. Med Hypotheses. 2021;149:110538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Zimba O, Gasparyan AY.. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. 2021;40(7):2611&#x2013;2619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7968918</ArticleId><ArticleId IdType="pubmed">33733315</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, et al. . Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Riitano F, Valentini P.. Pediatric inflammatory multisystem syndrome temporally related with SARS-CoV-2: Immunological similarities with acute rheumatic fever and toxic shock syndrome. Front Pediatr. 2020;8:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7516715</ArticleId><ArticleId IdType="pubmed">33042918</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, et al. . Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J Infect. 2021;83(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Moneim A. COVID-19 complications on the digestive system and liver: a current clinical and pathophysiological approach. Adv Dig Med. 2020.</Citation></Reference><Reference><Citation>Attal N, Martinez V, Bouhassira D.. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6(1):e884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850724</ArticleId><ArticleId IdType="pubmed">33537521</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizi SA, Azizi SA.. Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells. J Neurovirol. 2020;26(5):631&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465881</ArticleId><ArticleId IdType="pubmed">32876900</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, et al. . Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021;9(1):107&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser NP, De Micheli AJ, Schonk MM, et al. . Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197&#x2013;1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC, Rainger GE, Mason JC, et al. . Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science. Cardiovasc Res. 2020;116(14):2177&#x2013;2184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasmi A, Tippairote T, Mujawdiya PK, et al. . Neurological involvements of SARS-CoV2 infection. Mol Neurobiol. 2021;58(3):944&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7562688</ArticleId><ArticleId IdType="pubmed">33064267</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani RD, Dabas N, Goldberger JJ.. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17(11):1984&#x2013;1990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Moschonas IC, Tselepis AD.. SARS-CoV-2 infection and thrombotic complications: a narrative review. J Thromb Thrombolysis. 2021;52(1):111&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810105</ArticleId><ArticleId IdType="pubmed">33449290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo AS, Balogun SA, Williams OT, et al. . Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies. Pulm Med. 2020;2020:6175964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439160</ArticleId><ArticleId IdType="pubmed">32850151</ArticleId></ArticleIdList></Reference><Reference><Citation>P KM, Sivashanmugam K, Kandasamy M, et al. . Repurposing of histone deacetylase inhibitors: a promising strategy to combat pulmonary fibrosis promoted by TGF-&#x3b2; signalling in COVID-19 survivors. Life Sci. 2021;266:118883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831549</ArticleId><ArticleId IdType="pubmed">33316266</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts KA, Colley L, Agbaedeng TA, et al. . Vascular manifestations of COVID-19 &#x2013; thromboembolism and microvascular dysfunction. Front Cardiovasc Med. 2020;7:598400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649150</ArticleId><ArticleId IdType="pubmed">33195487</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S, Cui H, Wang T, et al. . Pain: a potential new label of COVID-19. Brain Behav Immun. 2020;87:159&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204693</ArticleId><ArticleId IdType="pubmed">32389704</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, et al. . A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021.doi:10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren AL, Digby RJ, Needham EJ.. Neurological update: COVID-19. J Neurol. 2021;268(11):4379&#x2013;4387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8085652</ArticleId><ArticleId IdType="pubmed">33929617</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni SE, Fabro AT, de Albuquerque A, et al. . Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev Respir Med. 2021;15(6):791&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">33902377</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel Almaguer-L&#xf3;pez RH-V, L&#xf3;pez-Mar&#xed;n L, Bacallao-M&#xe9;ndez R, et al. . COVID-19 and the kidneys: risk, damage and sequelae. MEDICC Rev. 2020;22(4):87&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">33295327</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Stang MB, Desenclos J, Flamant M, et al. . The good treatment, the bad virus, and the ugly inflammation: pathophysiology of kidney involvement during COVID-19. Front Physiol. 2021;12:613019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993058</ArticleId><ArticleId IdType="pubmed">33776785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile S, Strollo F, Mambro A, et al. . COVID-19, ketoacidosis and new-onset diabetes: are there possible cause and effect relationships among them? Diabetes Obes Metab. 2020;22(12):2507&#x2013;2508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436911</ArticleId><ArticleId IdType="pubmed">32790021</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimboli P, Camponovo C, Scappaticcio L, et al. . Thyroid sequelae of COVID-19: a systematic review of reviews. Rev Endocr Metab Disord. 2021;22(2):485&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8038866</ArticleId><ArticleId IdType="pubmed">33843008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsana L, Sonzogni A, Nasr A, et al. . Pulmonary post-mortem findings in a series of COVID-19 cases from Northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279758</ArticleId><ArticleId IdType="pubmed">32526193</ArticleId></ArticleIdList></Reference><Reference><Citation>De Michele S, Sun Y, Yilmaz MM, et al. . Forty postmortem examinations in COVID-19 patients. Am J Clin Pathol. 2020;154(6):748&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499554</ArticleId><ArticleId IdType="pubmed">32876680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Nair G, et al. . Microvascular injury in the brains of patients with Covid-19. N Engl J Med. 2021;384(5):481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Brauninger H, et al. . Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshdy A, Zaher S, Fayed H, et al. . COVID-19 and the heart: a systematic review of cardiac autopsies. Front Cardiovasc Med. 2020;7:626975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876291</ArticleId><ArticleId IdType="pubmed">33585586</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller T, Hirschbuhl K, Burkhardt K, et al. . Postmortem examination of patients with COVID-19. JAMA. 2020;323(24):2518&#x2013;2520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243161</ArticleId><ArticleId IdType="pubmed">32437497</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, et al. . Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3):e20202135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfamante GP, Perrucci GL, Falleni M, et al. . Evidence of SARS-CoV-2 transcriptional activity in cardiomyocytes of COVID-19 patients without clinical signs of cardiac involvement. Biomedicines. 2020;8(12):626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7767122</ArticleId><ArticleId IdType="pubmed">33352880</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F, Mazza M, Cavalli G, et al. . Can cytokine blocking prevent depression in COVID-19 survivors? J Neuroimmune Pharmacol. 2021;16(1):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587545</ArticleId><ArticleId IdType="pubmed">33107012</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun HJ, Coutavas E, Pine AB, et al. . Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection. JCI Insight. 2021;6(14)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410030</ArticleId><ArticleId IdType="pubmed">34111030</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al. . Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli SG, Altundag A, Yildirim D, et al. . Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol. 2021;28(1):28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571972</ArticleId><ArticleId IdType="pubmed">33132007</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, et al. . COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021;13(596):eabf8396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzini A, Aichner M, Sahanic S, et al. . Impact of vitamin D deficiency on COVID-19-a prospective analysis from the CovILD registry. Nutrients. 2020;12(9):2775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7551662</ArticleId><ArticleId IdType="pubmed">32932831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Boehm A, Sahanic S, et al. . Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients&#x2019; performance: a prospective observational cohort study. Respir Res. 2020;21(1):276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese G, Moltrasio C, Berti E, et al. . Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology. 2021;237(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801998</ArticleId><ArticleId IdType="pubmed">33232965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Raby E, Prasad Kumarasinghe S.. Cutaneous manifestations and dermatological sequelae of covid-19 infection compared to those from other viruses. Australas J Dermatol. 2021;62(2):141&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014733</ArticleId><ArticleId IdType="pubmed">33595840</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, et al. . Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21(3):313&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Xu J, Chen L, et al. . Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. Eur J Nucl Med Mol Imaging. 2021;48(8):2531&#x2013;2542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794623</ArticleId><ArticleId IdType="pubmed">33420914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FW, Fong SW, Young BE, et al. . Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021;10:e64909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano MC, Gambini G, Cozzupoli GM, et al. . Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study. Graefes Arch Clin Exp Ophthalmol. 2021;259(8):2157&#x2013;2165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848665</ArticleId><ArticleId IdType="pubmed">33523252</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa HA, Shaw TN, Knight SB, et al. . Alterations in T and B cell function persist in convalescent COVID-19 patients. Medicine. 2021;2(6):720&#x2013;735.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, et al. . Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2021;48(5):1460&#x2013;1466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al. . Cerebral micro-structural changes in COVID-19 patients &#x2013; An MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, et al. . Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48(10):3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Zhou M, Luo P, et al. . Plasma metabolomic profiling of patients recovered from coronavirus disease 2019 (COVID-19) with pulmonary sequelae 3 months after discharge. Clin Infect Dis. 2021;73(12):2228&#x2013;2239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929060</ArticleId><ArticleId IdType="pubmed">33596592</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schroeter N, Bormann T, et al. . Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med. 2021;62(7):910&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V, Sebastianelli L, Ferrazzoli D, et al. . Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19. Clin Neurophysiol. 2021;132(5):1138&#x2013;1143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954785</ArticleId><ArticleId IdType="pubmed">33774378</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, CACTUS Study Team, et al.. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968&#x2013;981 e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. . (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, et al. . Characterization and biomarker analyses of Post-COVID-19 complications and neurological manifestations. Cells. 2021;10(2):386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Wu J, Chen T, et al. . Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. 2021;131(8):e147329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. . Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et al. . Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, Hallqvist J, Gilmour KC, et al. . The long tail of covid-19&#x2019; &#x2013; the detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020;9:1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle ME, Appleton A, Liu QR, et al. . Human type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Am J Pathol. 2021;191(9):1511&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8179718</ArticleId><ArticleId IdType="pubmed">34102107</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter AG, Shields AM, Karim A, et al. . Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol. 2021;205(2):99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gomez A, Vitalle J, Gasca-Capote C, et al. . Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol. 2021;18(9):2128&#x2013;2139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294321</ArticleId><ArticleId IdType="pubmed">34290398</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al. . Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan A, Zreloff J, Moore MA, et al. . Prolonged symptoms after COVID-19 infection in outpatients. Open Forum Infect Dis. 2021;8(3):ofab060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928621</ArticleId><ArticleId IdType="pubmed">33732751</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur JM, Forrest JC, Boehme KW, et al. . Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021;16(9):e0257016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med. 2021;21(1):e68&#x2013;e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ.. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57(5):418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Islam M, Conroy K, et al. . COVID-19 symptoms over time: comparing Long-Haulers to ME/CFS. Fatigue. 2021;9(2):59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Abellan J, Padilla S, Fernandez-Gonzalez M, et al. . Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J Clin Immunol. 2021;41(7):1490&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung TYM, Chan AYL, Chan EW, et al. . Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020;9(1):2190&#x2013;2199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7586446</ArticleId><ArticleId IdType="pubmed">32940572</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, et al. . Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12(1):69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen LK, Dowd E, McKernan DP.. A role for viral infections in Parkinson&#x2019;s etiology? Neuronal Signal. 2018;2(2):NS20170166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373231</ArticleId><ArticleId IdType="pubmed">32714585</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>